Results
21,250 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Ugwumba Chidozie10% Owner |  CLNNClene Inc.Open-market sale | SELL | $57K 9,075 sh | Jan 12, 2026 traded Jan 9, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $57K 9,075 sh | Jan 12, 2026 traded Jan 9, 2026 | |
Ugwumba Chidozie10% Owner |
| CLNNClene Inc. Open-market sale |
| SELL |
| $180K 32.7K sh |
| Jan 12, 2026 traded Jan 12, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $174K 700 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $2.99M 632.9K sh | Jan 12, 2026 traded Jan 8, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $202K 780 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.34M 632.9K sh | Jan 12, 2026 traded Jan 9, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $219K 856 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 15 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.03M 41.2K sh | Jan 12, 2026 traded Jan 9, 2026 |
| 14 | Ugwumba Chidozie10% Owner | CLNNClene Inc. Open-market sale | SELL | $19K 3,195 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 14 | Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER |  PTCTPTC THERAPEUTICS, INC.Open-market sale · 10b5-1 plan | SELL | $192K 2,514 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 13 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 100 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 12 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $842K 33.8K sh | Jan 12, 2026 traded Jan 8, 2026 |
| 11 | Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER |  OMCLOMNICELL, INC.Open-market sale · 10b5-1 plan | SELL | $305K 6,106 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 11 | Schlosser MarioDirector, President of Technology & CTO |  OSCROscar Health, Inc.Open-market sale · 10b5-1 plan | SELL | $407K 23.0K sh | Jan 12, 2026 traded Jan 8, 2026 |
| 9 | Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $151K 7,500 sh | Jan 12, 2026 traded Jan 8, 2026 |
| 8 | Das SouvikChief Technology Officer |  CWANClearwater Analytics Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $241K 10.0K sh | Jan 12, 2026 traded Jan 8, 2026 |
| 8 | Tesh Thomas DChief Admin. Officer |  ROLROLLINS INCOpen-market sale · 10b5-1 plan | SELL | $144K 2,396 sh | Jan 12, 2026 traded Jan 9, 2026 |
| 4 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $747K 45.0K sh | Jan 12, 2026 traded Jan 12, 2026 |
| 45 | Gillai SaarDirector |  SMTCSEMTECH CORPOpen-market sale | SELL | $271K 3,600 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 44 | Mcrae Matthew BlakeDirector, CEO |  ARLOArlo Technologies, Inc.Open-market sale | SELL | $1.23M 90.1K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 41 | Zitkus LesterSVP, Land |  GPORGULFPORT ENERGY CORPOpen-market sale | SELL | $300K 1,606 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 41 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER | ARLOArlo Technologies, Inc. Open-market sale | SELL | $754K 55.0K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 41 | Zitkus LesterSVP, Land | GPORGULFPORT ENERGY CORP Open-market sale | SELL | $450K 2,439 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 38 | Zitkus LesterSVP, Land | GPORGULFPORT ENERGY CORP Open-market sale | SELL | $131K 700 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 35 | Kashani AliDirector, Chief Executive Officer |  SERVServe Robotics Inc. /DE/Open-market sale | SELL | $130K 9,088 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 35 | Parang TourajDirector, President & COO | SERVServe Robotics Inc. /DE/ Open-market sale | SELL | $57K 4,008 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 34 | Krumm KevinChief Financial Officer |  FLEXFLEX LTD.Open-market sale | SELL | $1.30M 21.2K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 33 | Busse BrianGENERAL COUNSEL | ARLOArlo Technologies, Inc. Open-market sale | SELL | $258K 18.8K sh | Jan 9, 2026 traded Jan 9, 2026 |
| 32 | Faga DanielDirector, President, CEO |  ANABANAPTYSBIO, INCOpen-market sale | SELL | $639K 14.3K sh | Jan 9, 2026 traded Jan 8, 2026 |
| 32 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.01M 25.2K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 32 | Abraham EuanChief Hardware & Mftg Offcr | SERVServe Robotics Inc. /DE/ Open-market sale | SELL | $17K 1,171 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 31 | Sutherland Vanessa AllenEVP, GC and Secretary |  PSXPhillips 66Open-market sale | SELL | $637K 4,394 sh | Jan 9, 2026 traded Jan 9, 2026 |
| 30 | Schacterle AmyChief Regulatory Officer |  ABOSAcumen Pharmaceuticals, Inc.Open-market sale | SELL | $2,176 1,097 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 30 | Lee Benjamin SeongChief Legal Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $5.64M 21.7K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 29 | Connelly JackPortfolio Manager |  IQIInvesco Quality Municipal Income TrustOpen-market sale | SELL | $39K 3,900 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 29 | Doherty John N.EVP, CFO |  BFLYButterfly Network, Inc.Open-market sale | SELL | $240K 60.2K sh | Jan 9, 2026 traded Jan 7, 2026 |
| 29 | Lizzul Paul F.Chief Medical Officer | ANABANAPTYSBIO, INC Open-market sale | SELL | $163K 3,650 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 26 | Doherty James J.President and CDO | ABOSAcumen Pharmaceuticals, Inc. Open-market sale | SELL | $12K 6,467 sh | Jan 9, 2026 traded Jan 8, 2026 |
| 26 | Lee Benjamin SeongChief Legal Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $1.63M 6,250 sh | Jan 9, 2026 traded Jan 7, 2026 |
| 26 | Doherty James J.President and CDO | ABOSAcumen Pharmaceuticals, Inc. Open-market sale | SELL | $3,379 1,700 sh | Jan 9, 2026 traded Jan 7, 2026 |